Bernadette Beyda, MD | |
14123 59th Ave, Flushing, NY 11355 | |
(718) 445-0566 | |
(718) 359-2592 |
Full Name | Bernadette Beyda |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 48 Years |
Location | 14123 59th Ave, Flushing, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740396159 | NPI | - | NPPES |
00724832 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 139854 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bernadette Beyda, MD 14123 59th Ave, Flushing, NY 11355 Ph: (718) 445-0566 | Bernadette Beyda, MD 14123 59th Ave, Flushing, NY 11355 Ph: (718) 445-0566 |
News Archive
Sword Diagnostics, Inc. is pleased to announce that the United States Patent Office (USPTO) has issued patent number 7,599,057 titled "Method and Apparatus for Detection of Biological Organisms using Raman Scattering" to the company.
To provide a better view of difficult to see tissue, Japanese researchers have miniaturized an imaging probe to fit inside a needle that can be inserted into the eye during eye surgery.
Tweaking a specific cell type's ability to absorb potassium in the brain improved walking and prolonged survival in a mouse model of Huntington's disease, reports a UCLA study published March 30 in the online edition of Nature Neuroscience. The discovery could point to new drug targets for treating the devastating disease, which strikes one in every 20,000 Americans.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent on methods of treating heart failure patients with bucindolol based on genetic testing.
A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer. Their report can be found in the February 2010 issue of The American Journal of Pathology.
› Verified 5 days ago
Wai Ping Chan, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13633 37th Ave Ste 4a, Flushing, NY 11354 Phone: 718-762-6462 Fax: 187-509-6467 | |
Julie Zang, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3808 Union St, Ste 3f, Flushing, NY 11354 Phone: 646-872-7148 | |
Dr. Robert Tankel, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 157 15 46th Ave, Flushing, NY 11355 Phone: 718-886-6663 Fax: 718-886-2681 | |
Dr. Stephanie W. Hu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 14472 Northern Blvd Ste 203, Flushing, NY 11354 Phone: 718-886-9000 | |
Dimitris C Zouzias, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3202 Union St, Flushing, NY 11354 Phone: 718-445-1550 Fax: 718-445-2843 | |
Dr. Jian Cui, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13620 38th Ave, Suite 5h, Flushing, NY 11354 Phone: 718-661-9554 Fax: 718-661-9556 | |
Hyun-soo Lee, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 14472 Northern Blvd Ste 203, Flushing, NY 11354 Phone: 718-886-9000 |